Motif Bio Share Discussion Threads

[small crow] 15/5/2017 16:13

There's several bios showing 2:1 ratios of buys:sells and yet showing 4-5% reductions today. Almost as if it's concerted action across the board. Sentiment on bios has been low since 2014 (around 30-40% lower valuations on average) but, generally, predictions have been it gaining ground now.

[big_cat] 15/5/2017 13:38

1.14m purchases and still price down!!

[ilovetowin] 15/5/2017 11:55

Better quality advisors on board now.

[1savvyinvestor] 15/5/2017 10:48

This should be a very safe entry point. Very surprised it has dropped back this far.

[nick rubens] 15/5/2017 09:57

Quiet a big move down today. I'm surprised the market isn't being more optimistic, but there you go. The thread has gone quiet too.

[ny boy] 15/5/2017 09:56

Added @ 29p, too good to miss

[pugugly] 12/5/2017 15:36

Gig_C : Chartwise looks to be heading back to the low estimeate.

[big_cat] 12/5/2017 14:50

From FT:
Share price forecast
The 3 analysts offering 12 month price targets for Motif Bio PLC have a median target of 90.00, with a high estimate of 125.00 and a low estimate of 25.00. The median estimate represents a 181.25% increase from the last price of 32.00.
Past 12 monthsNext 12 months50.0100.0150.0● High forecast: 125
High 290.6% 125.00
Med 181.3% 90.00
Low -21.9% 25.00

[small crow] 11/5/2017 18:03

No-one knows.

[rizler] 11/5/2017 15:58

What's the state of play for the funding for the revive 2 programme?? Anyone?

[ilovetowin] 11/5/2017 14:59

Feelings vs FactsRead the 18 April RNS Positive data readout Stick with facts and you won't go wrong here.Ducks lining up

[123js] 11/5/2017 10:48

I'm starting to get the feeling I don't fully understand the risk I'm taking here!Can only think that as mentioned by another post, the bad experience of the US listing & raise is darkening the shadow of the pending financing round...

[ilovetowin] 10/5/2017 22:36

Once it turns the herd will push it higherVery very close now

[big_cat] 10/5/2017 16:01

Too many warrant holders selling their shares thus depressing the price

[dstorey1] 10/5/2017 13:25

Looking at TA I am tempted to buy back in here but still can't overcome reservations as a result of US IPO saga. Love the science, not so the BOD.

[123js] 10/5/2017 13:06

Provided going after that additional worm doesn't allow the first one to wriggle away!But agree some long term 'expansion type' potential would be icing, but happy for a one trick cake at this point. And I would think to commercialise will need full attention!

[small crow] 10/5/2017 11:37

True, but you have to be one step ahead if you want the worm...

[123js] 10/5/2017 11:06

Let's get Iclaprim over the success line before spreading focus!

[small crow] 10/5/2017 07:12

These appointments encourage me that MTFB won't be stopping with the success of Iclaprim and that other developments are very likely already in hand, perhaps acquired through university links rather than created in-house?

[blueblood] 09/5/2017 13:21

The BoD should have been prepared with follow up to Revive1 results. At least they should have cleared up any Revive2 funding issues by now!

[rizler] 09/5/2017 12:50

Certainly testing my patience at the moment. Lol Just wondering if there is something behind such a drift. I personally didn't expect it to drop this much.But I also know your right. Clearly this will go up over time and cannot stay where it is simply based on the obvious info we already have.

[1savvyinvestor] 09/5/2017 12:30

Agreed Cudmore. Patience required for potential big rewards here.